Found 1607 matching trials
Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer
PHASE4Hyperkalemia (high potassium in blood) is a common condition found in kidne...
Location
The Rogosin Institute
Human Upper Extremity Allotransplantation
PHASE2Background: Millions of people each year sustain injuries, have tumors surg...
Location
Johns Hopkins University School of Medicine
Expanded Access Study for Renal Transplant Patients With Envarsus XR ™
N/AOpen label, multi-center, expanded access study for renal transplant patien...
Status
Approved For Marketing
Location
Multiple Locations
Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus
NAThe purpose of this study is to determine whether the Tacrolimus added to h...
Location
RSPC for organ and tissue transplantation, Minsk 9th clinic
The Differential Effects of 3 Different Immunosuppressive
N/AThe study is a laboratory investigation comparing the regulatory effects of...
Location
Northwestern Memorial Hospital
Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD
PHASE2To evaluate the safety of 3 regimens of short-term, low-dose systemic IMT a...
Location
Wills Eye Institute
Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis
PHASE1This pilot clinical trial studies the side effects and best dose of ruxolit...
Location
City of Hope Medical Center
Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen
PHASE3The purpose of this study is to demonstrate non-inferiority of an advagraf ...
Location
Universitätsklinikum Carl Gustav Carus
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
PHASE2RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Location
Rocky Mountain Cancer Centers
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
PHASE2Maraviroc (MVC) is a type of HIV medicine called a CCR5 inhibitor. This stu...
Location
UAB HIVTR-CCR5 Non-Network CRS